Your browser doesn't support javascript.
loading
ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.
Stolarova, Lenka; Kleiblova, Petra; Zemankova, Petra; Stastna, Barbora; Janatova, Marketa; Soukupova, Jana; Achatz, Maria Isabel; Ambrosone, Christine; Apostolou, Paraskevi; Arun, Banu K; Auer, Paul; Barnard, Mollie; Bertelsen, Birgitte; Blok, Marinus J; Boddicker, Nicholas; Brunet, Joan; Burnside, Elizabeth S; Calvello, Mariarosaria; Campbell, Ian; Chan, Sock Hoai; Chen, Fei; Chiang, Jian Bang; Coppa, Anna; Cortesi, Laura; Crujeiras-González, Ana; De Leeneer, Kim; De Putter, Robin; DePersia, Allison; Devereux, Lisa; Domchek, Susan; Efremidis, Anna; Engel, Christoph; Ernst, Corinna; Evans, D Gareth R; Feliubadaló, Lidia; Fostira, Florentia; Fuentes-Ríos, Olivia; Gómez-García, Encarna B; González, Sara; Haiman, Christopher; Hansen, Thomas van Overeem; Hauke, Jan; Hodge, James; Hu, Chunling; Huang, Hongyan; Ishak, Nur Diana Binte; Iwasaki, Yusuke; Konstantopoulou, Irene; Kraft, Peter; Lacey, James.
Afiliación
  • Stolarova L; Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Kleiblova P; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Zemankova P; Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Stastna B; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Janatova M; Department of Pathophysiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Soukupova J; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Achatz MI; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Ambrosone C; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Apostolou P; A.C. Camargo Cancer Center and Oncology Center, Hospital Sirio-Libanes, Sao Paulo, Brazil.
  • Arun BK; Department of Cancer Prevention & Control, Roswell Park Cancer Center, Buffalo, New York.
  • Auer P; WCHS Inc., Baltimore, Maryland.
  • Barnard M; Human Molecular Genetics Laboratory, INRaSTES, National Center for Scientific Research "Demokritos," Athens, Greece.
  • Bertelsen B; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Blok MJ; WHI, USA.
  • Boddicker N; Slone Epidemiology Center, Boston University, Boston, Massachusetts.
  • Brunet J; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
  • Calvello M; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Campbell I; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.
  • Chan SH; CARRIERS, USA.
  • Chen F; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Chiang JB; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL-IGTP-IDIBGI, L'Hospitalet, Barcelona, Spain.
  • Coppa A; School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin.
  • Cortesi L; WWHS, Charlotte, North Carolina.
  • Crujeiras-González A; Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • De Leeneer K; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • De Putter R; Cancer Genetics Service, National Cancer Centre, Singapore, Singapore.
  • DePersia A; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Devereux L; Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Domchek S; MEC, USA.
  • Efremidis A; Cancer Genetics Service, National Cancer Centre, Singapore, Singapore.
  • Engel C; Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Ernst C; Department of Oncology and Haematology, Modena University Hospital, Modena, Italy.
  • Evans DGR; Fundacion Publica Galega de Medicina Xenomica, Santiago de Compostela, Spain.
  • Feliubadaló L; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
  • Fuentes-Ríos O; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
  • Gómez-García EB; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
  • González S; Center for Medical Genetics, NorthShore University Health System, Evanston, Illinois.
  • Haiman C; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Hansen TVO; Lifepool, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Hauke J; CARRIERS, USA.
  • Hodge J; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Hu C; Clinical Cancer Genetics and Family Consultants, CLINICAGENE, Athens Medical Center, Athens, Greece.
  • Huang H; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Ishak NDB; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Iwasaki Y; Manchester Centre for Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, Manchester, United Kingdom.
  • Konstantopoulou I; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  • Kraft P; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL-IGTP-IDIBGI, L'Hospitalet, Barcelona, Spain.
  • Lacey J; Molecular Diagnostics Laboratory, INRaSTES, National Center for Scientific Research "Demokritos," Athens, Greece.
Clin Cancer Res ; 29(16): 3037-3050, 2023 08 15.
Article en En | MEDLINE | ID: mdl-37449874
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos